Section of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Section of Gastroenterology, VA Medical Center, Philadelphia, Pennsylvania, USA.
Colorectal Dis. 2017 Dec;19(12):1108-1116. doi: 10.1111/codi.13721.
The standard approach for the surgical management of colorectal cancer (CRC) in the setting of ulcerative colitis (UC) involves total proctocolectomy (TPC). However, some patients also undergo a partial resection (PR). This may be an attractive option in older patients with a high risk for surgery. The aim of this study was to compare the risk of metachronous cancer after PR or TPC for CRC in the setting of UC.
This was a retrospective cohort study conducted through the Nationwide Veterans Affairs Healthcare System (VA). Patients who had UC and underwent a PR or TPC for CRC were followed from the time of their surgery to their most recent clinical follow-up. The primary outcome was development of metachronous cancer in the PR group. Secondary outcomes included surgical and medical outcomes.
Fifty-nine patients were included: 24 (40.7%) underwent PR and 35 (59.3%) underwent TPC. The median age at cancer diagnosis was 73.0 and 61.7 years in PR and TPC groups, respectively (P < 0.0005). Amongst patients undergoing PR, 15 (60%) had no active UC at the time of surgery, whereas in patients undergoing TPC, at the time of surgery eight (23.5%) had no active UC (P = 0.005). No patient who underwent a partial colectomy developed a metachronous cancer in the retained colonic segment during the follow-up period (median 7 years).
Our study suggests that PR for CRC in the setting of UC may be a viable option in a selected cohort of patients, especially among the elderly.
在溃疡性结肠炎(UC)背景下,结直肠癌(CRC)的标准手术治疗方法包括全直肠结肠切除术(TPC)。然而,一些患者也接受部分切除术(PR)。对于手术风险较高的老年患者,这可能是一种有吸引力的选择。本研究旨在比较 UC 背景下 CRC 行 PR 或 TPC 后发生异时性癌症的风险。
这是一项通过全国退伍军人事务部医疗保健系统(VA)进行的回顾性队列研究。患有 UC 并接受 PR 或 TPC 治疗 CRC 的患者,从手术时开始随访至最近一次临床随访。主要结局是 PR 组发生异时性癌症。次要结局包括手术和医疗结果。
共纳入 59 例患者:24 例(40.7%)接受 PR,35 例(59.3%)接受 TPC。PR 和 TPC 组癌症诊断时的中位年龄分别为 73.0 和 61.7 岁(P<0.0005)。在接受 PR 的患者中,15 例(60%)在手术时无活动性 UC,而在接受 TPC 的患者中,8 例(23.5%)在手术时无活动性 UC(P=0.005)。在随访期间,接受部分结肠切除术的患者中没有保留结肠段发生异时性癌症(中位随访时间 7 年)。
我们的研究表明,在 UC 背景下,PR 治疗 CRC 可能是一种可行的选择,尤其是在老年患者中。